Deep Brain Stimulation for Spinocerebellar Ataxias

Not yet recruiting at 1 trial location
ND
GB
Overseen ByGordon Baltuch, MD, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Gordon H. Baltuch
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to evaluate the safety and feasibility of deep brain stimulation (DBS) in the deep cerebellar nuclei (DCN) in patients with Spinocerebellar Ataxia (SCA) types 1 and 3.

Primary Objective: The incidence and nature of treatment-related adverse events across the entire study, including serious treatment-related adverse events such as intracerebral hemorrhage, infection, and serious or unanticipated adverse device effects (SADEs and UADEs).

Secondary/Exploratory Objectives:

* Evaluation of the effect of Dentate Nucleus (DN) - Deep Brain Stimulation (DBS). Ataxia severity will be quantified using the Scale of Assessment and Rating of Ataxia (SARA), Patient-Reported Outcome Measure of Ataxia (PROM-Ataxia), and kinematics.

* To characterize electrophysiological activity across the cerebellothalamocorticomuscular (CTCM) network at rest and during motor behaviors.

* To examine how DN-DBS modulates oscillatory activity and coupling across the CTCM circuit in relation to improvements in controlling ataxia.

Who Is on the Research Team?

GB

Gordon Baltuch, MD

Principal Investigator

CUIMC

SK

Sheng-Han Kuo, MD

Principal Investigator

CUIMC

Are You a Good Fit for This Trial?

This trial is for people diagnosed with Spinocerebellar Ataxia type 1 or type 3. Participants should be adults who meet specific medical criteria and do not have conditions that would make surgery unsafe.

Inclusion Criteria

Subject is available for all follow-up visits during the length of the study
Subject is able and willing to give informed consent and attend all study visits
Subject has a minimum 6th grade reading level, as determined by the Rapid Estimate of Adult Literacy in Medicine (REALM) scale
See 4 more

Exclusion Criteria

I have been diagnosed with epilepsy.
I cannot stop my blood thinner or anti-platelet medication for the study.
Subject has a major active psychiatric illness that may interfere with the study, such as psychiatric disorders or severe personality disorders
See 15 more

What Are the Treatments Tested in This Trial?

Interventions

  • Deep Brain Stimulation (DBS) System

Trial Overview

The study is testing the safety and practicality of using deep brain stimulation (DBS) in a part of the brain called the cerebellar nuclei to help manage symptoms in SCA1 and SCA3 patients.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: DBS InterventionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Gordon H. Baltuch

Lead Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator

Trials
1,403
Recruited
655,000+